rLP2086 vaccine
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for rLP2086 vaccine, covering 2008-05-08 to 2015-06-04. Get the full timeline:
Most recent: Clinical Trial Update: A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years [Phase 2]